Healthy pregnancy hub

Temazepam (Restoril®)

Last Update: 02 Oct 2025

Welcome to our fact sheet on temazepam during pregnancy and breastfeeding or chestfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (January 2025).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is temazepam?

Temazepam is a medication that has been used to treat insomnia (having a hard time falling asleep or staying asleep). Temazepam is in a class of medications called benzodiazepines. It is sold under the brand name Restoril®.  

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Your healthcare providers can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy.  

If you plan to stop this medication, your healthcare provider might suggest that you slowly lower the dose instead of stopping all at once. Stopping this medication suddenly can cause some people to have withdrawal symptoms. It is not known what effects, if any, withdrawal could have on a pregnancy.  

2. What does research say about the risks during pregnancy?

I take temazepam. Can it make it harder for me to get pregnant?

It is not known if using temazepam could make it harder to get pregnant. 

Does taking temazepam increase the chance of miscarriage?   

Miscarriage is common and can occur in any pregnancy for many different reasons. One study suggested that temazepam might increase the chance of miscarriage. As there can be many causes of miscarriage, it is hard to know if a medication, the medical condition being treated, or other factors are the cause of a miscarriage.  

Does taking temazepam increase the chance of birth defects?

Birth defects can happen in any pregnancy for different reasons. Out of all babies born each year, about 3 out of 100 (3%) will have a birth defect. We look at research studies to try to understand if an exposure, like temazepam, might increase the chance of birth defects in a pregnancy.  

A study of 379 children exposed to temazepam in the first trimester of pregnancy did not find a higher chance of birth defects.  

Does taking temazepam in pregnancy increase the chance of other pregnancy-related problems? 

Studies have not been done to see if temazepam can increase the chance of pregnancy-related problems such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth).   

I need to take temazepam throughout my entire pregnancy. Will it cause symptoms in my baby after birth?  

The use of benzodiazepines during pregnancy near the time of delivery could cause temporary symptoms in newborns soon after birth. These symptoms are sometimes referred to as withdrawal. Symptoms can include irritability, crying, sleep disturbances, tremors, jitteriness, trouble breathing, or muscle weakness. Not all babies exposed to benzodiazepines will have these symptoms. It is not known if the use of temazepam in pregnancy can cause these symptoms in a newborn. It is important that your healthcare providers know you are taking temazepam so that if symptoms occur your baby can get the care that is best for them.  

Can I take my benzodiazepine with diphenhydramine? 

A single human report and animal data have suggested that the combination of temazepam and diphenhydramine (Benadryl®) might increase the chance for stillbirth or for infant death shortly after birth. People taking temazepam should talk with their healthcare provider before taking diphenhydramine during their pregnancy. For more information, consult the fact sheet on diphenhydramine here.

Does taking temazepam in pregnancy affect future behavior or learning for the child?

Studies have not been done to see if temazepam can increase the chance of behavior or learning issues for the child.   

3. Breastfeeding​/ chestfeeding​ while taking temazepam

Temazepam has not been well studied for use while nursing. Only small amounts of temazepam get into human milk. No side effects were reported in approximately 10 infants who were exposed to temazepam through human milk. Children exposed to temazepam through nursing should be watched for excessive drowsiness (being too sleepy). If you suspect the baby has any symptoms (such as being very sleepy, poor weight gain, low muscle tone [floppiness], or slowed breathing), contact the child’s healthcare provider. Be sure to talk to your healthcare provider about all your breastfeeding or chestfeeding questions. 

4. What about fathers and sperm donors?

If a male takes temazepam, could it affect fertility or increase the chance of birth defects?

Studies have not been done to see if temazepam could affect men’s fertility (ability to get a partner pregnant) or increase the chance of birth defects. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Temazepam (Restoril®) is a medication from the benzodiazepines group that is used to help people sleep.  
  • It’s not clear if temazepam affects fertility or increases the chance of miscarriage.  
  • Birth defects happen in 3 out of 100 pregnancies, even without medication. One study found no increase in the risk of birth defects. 
  • There is no clear research showing if temazepam causes other problems during pregnancy, like premature birth or low birth weight. 
  • If taken near delivery, temazepam might cause symptoms in newborns, such as crying, shaking, trouble sleeping, or weak muscles. Not all babies will have symptoms. 
  • Temazepam passes into human milk in small amounts. In a small group of babies, no problems were seen, but it remains important to watch for side effects. 
  • Always talk to your healthcare provider before making any changes to your medication during pregnancy or breastfeeding/ chestfeeding.

References

Please click here for references. 

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Sasha Bernatsky
Research Institute of the McGill University Health Centre
Evelyne Rey
CHU Sainte-Justine
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Our interactive tools

Ask your questions and receive help from our personalized AI.

Try it now!

Explore our reading assistance tool.

Test them out today!

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University